首页
订购/客服:400-666-5481

KCC 07,MBD2(甲基-CpG结合域蛋白2)抑制剂

    
10mM in DMSO

KCC-07

源叶(MedMol)
V54169 一键复制产品信息
315702-75-1
C14H11N3OS
269.32
3-((4-(吡啶-2-基)噻唑-2-基)氨基)苯酚;3-((4-(Pyridin-2-yl)thiazol-2-yl)amino)phenol;KCC-07
货号 规格 价格 上海 北京 珠海 重庆 武汉 购买数量
V54169-1ml
10mM in DMSO

¥870.00

货期:3-5天 - - - -
产品介绍 参考文献 质检证书(COA) 摩尔浓度计算器 相关产品
产品描述:

KCC-07 is a potent, selective and brain-penetrant MBD2 (methyl-CpG-binding domain protein 2) inhibitor. KCC-07 prevents binding of MBD2 to methylated DNA and activates brain specific angiogenesis inhibitor 1 (BAI1) inducing anti-proliferative BAI1/p53/p21 signaling. Anticancer activity

靶点: MBD2 (methyl-CpG-binding domain protein 2);DNAAlkylator/Crosslinker
体外研究: KCC-07 (10 μM; 72 hours; MB cells) treatment clearly inhibited MB cell growth in vitro, consistent with induction of anti-proliferative BAI1/p53/p21 signaling.

KCC-07 (10 μM; 48 hours; MB cells) treatment largely abrogates MBD2 binding to the ADGRB1 promoter and restores BAI1 mRNA and protein expression in BAI1-silent MB cells.
体内研究: KCC-07 (100 mg/kg; intraperitoneal injection; 5 days/week; athymic nude mice) treatment inhibits tumor growth and significantly extends the survival of MB xenografts in vivo. Animal Model: Outbred athymic nude mice (females; 8-10 weeks old) injected with MB cells Dosage: 100 mg/kg Administration: Intraperitoneal injection; 5 days/weekResult: Significantly extended the survival of MB xenografts in vivo.
参考文献: 1. Dan Zhu, et al. BAI1 Suppresses Medulloblastoma Formation by Protecting p53 From Mdm2-Mediated Degradation. Cancer Cell. 2018 Jun 11;33(6):1004-1016.e5.
溶解性: Soluble  in  DMSO
保存条件: -80℃(运输条件:冰袋低温运输)
配置溶液浓度参考:
1mg 5mg 10mg
1 mM 3.713 ml 18.565 ml 37.131 ml
5 mM 0.743 ml 3.713 ml 7.426 ml
10 mM 0.371 ml 1.857 ml 3.713 ml
50 mM 0.074 ml 0.371 ml 0.743 ml
注意: 部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。

参考文献

质检证书(COA)

如何获取质检证书(COA)?
请输入货号和一个与之匹配的批号。
例如:
批号:JS298415 货号:S20001-25g
在货品标签上如何找到货号和批号?

摩尔浓度计算器

质量 (mg) = 浓度 (mM) x 体积 (mL) x 分子摩尔量 (g/mol)

=
×
×